• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

经皮冠状动脉介入治疗在既往冠状动脉旁路移植术患者的移植物与自身血管中的长期临床结果。

Long-term clinical outcome after percutaneous coronary intervention in grafts vs native vessels in patients with previous coronary artery bypass grafting.

机构信息

Patras University Hospital, Cardiology Department, Patras, Greece.

出版信息

Can J Cardiol. 2011 Nov-Dec;27(6):716-24. doi: 10.1016/j.cjca.2011.08.115. Epub 2011 Oct 22.

DOI:10.1016/j.cjca.2011.08.115
PMID:22019279
Abstract

BACKGROUND

The long-term clinical outcome of patients with previous coronary artery bypass grafting (CABG), undergoing percutaneous coronary intervention (PCI) is not clear.

METHODS

Observational, retrospective study of post-CABG patients, who underwent PCI in either a graft or a native vessel.

RESULTS

Out of 221 consecutive patients, those with PCI in both native vessel and graft (N=16) and missing follow-up data (N=15) were excluded. Out of the remaining 190 patients (age 67.9±9.6 years; 90.0% men), the graft-PCI group (N=88) had more occluded native vessels (2.1±0.8 vs 1.6±0.8; P<0.001), and fewer totally occluded grafts (0.55±0.6 vs 0.75±0.8; P=0.05) compared with the native vessel-PCI group (N=102). On follow-up (median duration 28 months), the incidence of major adverse cardiac events (MACEs), cardiac death, and repeat revascularization was higher in graft-PCI group compared with native vessel-PCI group (43.2% vs 19.6%, log-rank P<0.001; 19.3% vs 6.9%, log-rank P=0.008; and 23.9% vs 12.7%, log-rank P=0.02, respectively). Graft-PCI was independently associated with higher risk for major adverse cardiac events (hazard ratio [HR], 2.84; 95% confidence interval [CI], 1.45-5.57; P=0.002), cardiac death (HR, 3.44; 95% CI, 1.16-10.22; P=0.03) and repeat revascularization (HR, 2.41; 95% CI, 1.02-5.72; P=0.046).

CONCLUSIONS

Post-CABG patients, undergoing graft compared with native vessel-PCI, have worse long-term clinical outcome. Prospective studies are needed to elucidate the optimal revascularization strategy for such patients.

摘要

背景

既往行冠状动脉旁路移植术(CABG)的患者再次行经皮冠状动脉介入治疗(PCI)的长期临床结局尚不清楚。

方法

对再次行 PCI 的 CABG 后患者进行观察性、回顾性研究,这些患者的 PCI 是在桥血管或自身血管中进行的。

结果

在 221 例连续患者中,排除了在自身血管和桥血管中均行 PCI(N=16)和失访(N=15)的患者。在其余 190 例患者(年龄 67.9±9.6 岁;90.0%为男性)中,桥血管 PCI 组(N=88)的未闭塞自身血管更多(2.1±0.8 比 1.6±0.8;P<0.001),而完全闭塞的桥血管更少(0.55±0.6 比 0.75±0.8;P=0.05)。与自身血管 PCI 组(N=102)相比,在随访期间(中位时间 28 个月),桥血管 PCI 组主要不良心脏事件(MACE)、心脏性死亡和再次血运重建的发生率更高(43.2%比 19.6%,log-rank P<0.001;19.3%比 6.9%,log-rank P=0.008;23.9%比 12.7%,log-rank P=0.02)。桥血管 PCI 与更高的 MACE 风险独立相关(风险比[HR],2.84;95%置信区间[CI],1.45-5.57;P=0.002)、心脏性死亡(HR,3.44;95%CI,1.16-10.22;P=0.03)和再次血运重建(HR,2.41;95%CI,1.02-5.72;P=0.046)。

结论

与自身血管 PCI 相比,CABG 后患者行桥血管 PCI 具有更差的长期临床结局。需要前瞻性研究来阐明此类患者的最佳血运重建策略。

相似文献

1
Long-term clinical outcome after percutaneous coronary intervention in grafts vs native vessels in patients with previous coronary artery bypass grafting.经皮冠状动脉介入治疗在既往冠状动脉旁路移植术患者的移植物与自身血管中的长期临床结果。
Can J Cardiol. 2011 Nov-Dec;27(6):716-24. doi: 10.1016/j.cjca.2011.08.115. Epub 2011 Oct 22.
2
Feasibility of percutaneous coronary interventions in early postcoronary artery bypass graft occlusion or stenosis.冠状动脉搭桥术后早期冠状动脉闭塞或狭窄时经皮冠状动脉介入治疗的可行性
J Interv Cardiol. 2007 Jun;20(3):204-8. doi: 10.1111/j.1540-8183.2007.00258.x.
3
Percutaneous coronary intervention in native arteries versus bypass grafts in prior coronary artery bypass grafting patients: a report from the National Cardiovascular Data Registry.经皮冠状动脉介入治疗在原发性动脉与先前冠状动脉旁路移植术患者中的旁路移植术:来自国家心血管数据注册中心的报告。
JACC Cardiovasc Interv. 2011 Aug;4(8):844-50. doi: 10.1016/j.jcin.2011.03.018.
4
Percutaneous revascularization of ostial saphenous vein graft stenoses.隐静脉桥开口处狭窄的经皮血管重建术。
J Am Coll Cardiol. 1995 Oct;26(4):955-60. doi: 10.1016/0735-1097(95)00266-X.
5
Comparison of long-term (4-year) outcomes of patients with unprotected left main coronary artery narrowing treated with drug-eluting stents versus coronary-artery bypass grafting.药物洗脱支架与冠状动脉旁路移植术治疗无保护左主干冠状动脉狭窄患者的长期(4 年)结局比较。
Am J Cardiol. 2010 Jun 15;105(12):1728-34. doi: 10.1016/j.amjcard.2010.01.353.
6
Superior long term outcome associated with native vessel versus graft vessel PCI following secondary PCI in patients with prior CABG.对于既往接受冠状动脉旁路移植术(CABG)的患者,在二次经皮冠状动脉介入治疗(PCI)后,使用自身血管进行PCI与使用移植血管进行PCI相比,长期预后更佳。
Int J Cardiol. 2017 Feb 1;228:563-569. doi: 10.1016/j.ijcard.2016.11.031. Epub 2016 Nov 14.
7
Percutaneous revascularization in patients with previous coronary artery bypass graft surgery. Immediate and 1-year clinical outcomes.曾接受冠状动脉旁路移植术患者的经皮血管重建。即刻及1年临床结局。
Int J Cardiol. 2009 May 15;134(2):201-6. doi: 10.1016/j.ijcard.2008.01.042. Epub 2008 May 27.
8
Incidence, predictors and outcomes of incomplete revascularization after percutaneous coronary intervention and coronary artery bypass grafting: a subgroup analysis of 3-year SYNTAX data.经皮冠状动脉介入治疗和冠状动脉旁路移植术后不完全血运重建的发生率、预测因素和结局:SYNTAX 数据 3 年亚组分析。
Eur J Cardiothorac Surg. 2012 Mar;41(3):535-41. doi: 10.1093/ejcts/ezr105. Epub 2011 Dec 21.
9
Preprocedural white blood cell count and major adverse cardiac events late after percutaneous coronary intervention in saphenous vein grafts.术前白细胞计数与隐静脉移植血管经皮冠状动脉介入治疗术后晚期主要不良心脏事件
Am J Cardiol. 2005 Aug 15;96(4):515-8. doi: 10.1016/j.amjcard.2005.03.103.
10
Outcomes of patients with acute myocardial infarction from a saphenous vein graft culprit undergoing percutaneous coronary intervention.经皮冠状动脉介入治疗的隐静脉桥罪犯病变急性心肌梗死患者的结局。
Catheter Cardiovasc Interv. 2011 Jul 1;78(1):23-9. doi: 10.1002/ccd.22873. Epub 2011 Mar 16.

引用本文的文献

1
Percutaneous Coronary Intervention of Native Artery Versus Bypass Graft in Patients with Prior Coronary Artery Bypass Graft Surgery.冠状动脉旁路移植术后患者行冠状动脉介入治疗:自体血管与移植血管的比较
Rev Cardiovasc Med. 2022 Jun 24;23(7):232. doi: 10.31083/j.rcm2307232. eCollection 2022 Jul.
2
Long-term outcomes of percutaneous coronary intervention in grafts and native vessels in coronary artery bypass grafting patients with diabetes mellitus.糖尿病冠状动脉旁路移植术患者移植血管和自身血管经皮冠状动脉介入治疗的长期预后
J Thorac Dis. 2019 Nov;11(11):4798-4806. doi: 10.21037/jtd.2019.10.33.
3
Long-Term Outcome of Consecutive Patients With Previous Coronary Bypass Surgery, Treated With Newer-Generation Drug-Eluting Stents.
既往冠状动脉旁路移植术后患者应用新一代药物洗脱支架的长期预后。
J Am Heart Assoc. 2018 Jan 30;7(3):e007212. doi: 10.1161/JAHA.117.007212.
4
Percutaneous coronary intervention strategies and prognosis for graft lesions following coronary artery bypass grafting.冠状动脉旁路移植术后移植血管病变的经皮冠状动脉介入治疗策略及预后
Exp Ther Med. 2015 May;9(5):1656-1664. doi: 10.3892/etm.2015.2366. Epub 2015 Mar 16.
5
Saphenous vein graft interventions.大隐静脉移植干预措施。
Curr Treat Options Cardiovasc Med. 2014 May;16(5):301. doi: 10.1007/s11936-014-0301-x.
6
Economic burden of acute coronary syndrome in South Korea: a national survey.韩国急性冠状动脉综合征的经济负担:一项全国性调查。
BMC Cardiovasc Disord. 2013 Aug 8;13:55. doi: 10.1186/1471-2261-13-55.
7
Thrombus extraction catheters vs. angiojet rheolytic thrombectomy in thrombotic lesions/SV grafts.血栓切除术导管与Angiojet流变血栓切除术治疗血栓性病变/自体静脉移植物的对比
Curr Cardiol Rev. 2012 Aug;8(3):202-8. doi: 10.2174/157340312803217265.